Wall Street analysts were impressed by data showing competitive rates of weight loss for Viking’s therapy, but shares in the ...
Viking Therapeutics shares reversed course to fall 11% on Monday as focus shifted to the drug developer's ability to mass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback